An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study

Michael R. Savona, Olatoyosi Odenike, Philip C. Amrein, David P. Steensma, Amy E. DeZern, Laura C. Michaelis, Stefan Faderl, Wael Harb, Hagop Kantarjian, James Lowder, Aram Oganesian, Mohammad Azab, Guillermo Garcia-Manero

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences